<p>Box (median and IQR) and whisker (10<sup>th</sup> - 90<sup>th</sup> percentiles) plots of the magnitude of humoral immune responses elicited by Cervarix<sup>®</sup> (Blue) and Gardasil<sup>®</sup> (Red) vaccinees in the (A) neutralization assay, (B) binding assay or (C) B cell ELISpot assay against the indicated vaccine (HPV16, HPV18) and non-vaccine (HPV31, HPV45) genotypes. * p<0.05; ** p<0.01; *** p<0.001.</p
S2a. Antibodies against Wuhan-hu-1 spike protein as measured by ELISA at baseline and two weeks foll...
In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral an...
<p>Neutralization responses for each vaccinee category were grouped according to blood draw days. Ca...
<p>Percentage of serum samples neutralizing indicated number of A9 (top panel) or A7 (bottom panel) ...
<p>Percentage of vaccinees with neutralization titers of ≥20 (left panels) and GMT (right panels) ag...
<div><p>Background</p><p>Human papillomavirus (HPV) vaccines confer protection against the oncogenic...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
a<p>Cervarix n = 91; Gardasil n = 97. <i>p</i> values <0.05 highlighted in bold type. N/A, not appli...
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing antibody titers against HPV16 PsVs in mouse ser...
<p><sup><i>a</i></sup> Median (inter-quartile range, IQR) for immune measures against vaccine (HPV16...
Human Papillomavirus (HPV) bivalent (Cervarix®) and quadrivalent (Gardasil®) vaccines demonstrate ro...
<p>The Y axis values indicate the group median frequency of antibody secreting cells (ASCs) per 10<s...
<p>(A) Neutralization titers were normalized to IgG levels in serum and genital samples for HPV16 (l...
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing activities against HPV16 PsVs in mouse sera imm...
<p>(A) Colorimetric ELISA based analysis of HSV-1 reactive polyclonal IgG produced 21 days post vacc...
S2a. Antibodies against Wuhan-hu-1 spike protein as measured by ELISA at baseline and two weeks foll...
In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral an...
<p>Neutralization responses for each vaccinee category were grouped according to blood draw days. Ca...
<p>Percentage of serum samples neutralizing indicated number of A9 (top panel) or A7 (bottom panel) ...
<p>Percentage of vaccinees with neutralization titers of ≥20 (left panels) and GMT (right panels) ag...
<div><p>Background</p><p>Human papillomavirus (HPV) vaccines confer protection against the oncogenic...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
a<p>Cervarix n = 91; Gardasil n = 97. <i>p</i> values <0.05 highlighted in bold type. N/A, not appli...
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing antibody titers against HPV16 PsVs in mouse ser...
<p><sup><i>a</i></sup> Median (inter-quartile range, IQR) for immune measures against vaccine (HPV16...
Human Papillomavirus (HPV) bivalent (Cervarix®) and quadrivalent (Gardasil®) vaccines demonstrate ro...
<p>The Y axis values indicate the group median frequency of antibody secreting cells (ASCs) per 10<s...
<p>(A) Neutralization titers were normalized to IgG levels in serum and genital samples for HPV16 (l...
<p>(A) Anti-HPV16 L1 IgG titers and (B) neutralizing activities against HPV16 PsVs in mouse sera imm...
<p>(A) Colorimetric ELISA based analysis of HSV-1 reactive polyclonal IgG produced 21 days post vacc...
S2a. Antibodies against Wuhan-hu-1 spike protein as measured by ELISA at baseline and two weeks foll...
In order to assess HPV-specific IgG characteristics, we evaluated multiple aspects of the humoral an...
<p>Neutralization responses for each vaccinee category were grouped according to blood draw days. Ca...